Comparative Efficacy of a Once-Daily Controlled-Release Formulation of Glipizide and Immediate-Release Glipizide in Patients With NIDDM

Diabetes Care ◽  
1994 ◽  
Vol 17 (12) ◽  
pp. 1460-1464 ◽  
Author(s):  
M. Berelowitz ◽  
C. Fischette ◽  
W. Cefalu ◽  
D. S. Schade ◽  
T. Sutfin ◽  
...  
Keyword(s):  
Controlled Release ◽  
Immediate Release ◽  
Comparative Efficacy ◽  
Release Formulation ◽  
Once Daily ◽  
Controlled Release Formulation

Absence of pre-dose rebound phenomena with once daily 5-ISMN in a controlled-release formulation

1992 ◽  
Vol 13 (6) ◽  
pp. 814-817 ◽  
Author(s):  
G. OLSSON ◽  
J. ALLGÉN ◽  
O. AMTORP ◽  
G. NYBERG ◽  
J. O. PARKER
Keyword(s):  
Controlled Release ◽  
Release Formulation ◽  
Once Daily ◽  
Controlled Release Formulation

Anti-anginal Efficacy of a Controlled-Release Formulation of lsosorbide-5-mononitrate Once Daily in Angina Patients on Chronic β-Blockade

2009 ◽  
Vol 223 (3) ◽  
pp. 219-225 ◽  
Author(s):  
ARTO UUSITALO ◽  
OLAVI KEYRILÄINEN ◽  
RISTO HÄRKÖNEN ◽  
PENTI RAUTIO ◽  
NINA REHNQVIST ◽  
...  
Keyword(s):  
Controlled Release ◽  
Release Formulation ◽  
Once Daily ◽  
Controlled Release Formulation

Prophylactic Treatment of Classical and Non-Classical Migraine With Metoprolol—a Comparison with Placebo

Cephalalgia ◽  
1983 ◽  
Vol 3 (4) ◽  
pp. 207-212 ◽  
Author(s):  
P. G. Andersson ◽  
S. Dahl ◽  
J. H. Hansen ◽  
P. E. Hansen ◽  
C. Hedman ◽  
...  
Keyword(s):  
Controlled Release ◽  
Severity Score ◽  
Prophylactic Treatment ◽  
Double Blind ◽  
Release Formulation ◽  
Once Daily ◽  
Controlled Release Formulation

A double-blind investigation with parallel groups was carried out in three Danish neurological clinics to evaluate the effect of metoprolol (Beloc(r), Betaloc(r), Seloken(r)) versus placebo in migraine patients. 71 patients were included; 62 completed the study. The following parameters were used in the evaluation: frequency of headache attacks, days with migraine, severity score (days intensity), and the consumption of pain-relieving tablets. The results of the study show that metoprolol 200 mg in Durules(r) (a controlled release formulation) once daily is more effective regarding all evaluated parameters than placebo and that metoprolol is well tolerated.

Sign in / Sign up

Export Citation Format

Share Document